हिंदी में पढ़ें
Banking & Financial Services
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
We have to focus on the seriousness of COVID-19 in India: Kiran Mazumdar Shaw
Thu, Apr 02, 2020
The virus is spreading and we will have to pay attention to its seriousness, i.e. how many critical cases do we have, how many people do we have in ICU and ventilators because it will allow us to know about the kind of pressure on the hospitals.
Stocks in Focus on March 12: SBI, Yes Bank to IndiGo; here are expected 5 Newsmakers of the Day
Thu, Mar 12, 2020
Stocks in Focus on March 12: SBI, Yes Bank, IndiGo, L&T and Biocon are the expected 5 newsmakers throughout the intraday trade.
Biocon's Kiran Mazumdar-Shaw awarded 'Order of Australia'
Sun, Jan 19, 2020
Biopharmaceutical company Biocon on Saturday said that its Chairperson and Managing Director Kiran Mazumdar-Shaw has been awarded the -- 'Order of Australia' -- Australia's highest civilian honour.
Stocks in Focus on October 10: TCS, Tata Steel to REL; here are the 5 Newsmakers of the Day
Fri, Oct 11, 2019
Tata Consultancy Services or TCS, Tata Steel, Biocon, Religare Enterprises and NCC are the five stocks that are expected to remain newsmakers throughout the day.
Stocks in Focus on September 3: Biocon, KNR Construction to JK Tyre; here are the 5 Newsmakers of the Day
Tue, Sep 03, 2019
Certain stocks came in news after the market was closed on Friday and can have an impact on the market when it reopens today after three days break.
Sensex nudge down, Nifty retains 11K levels; Vodafone Idea, Reliance Capital, Biocon stocks bleed
Tue, Aug 20, 2019
The BSE Sensex nudged 74 points down and closed at 37,328 levels while the 50-stock Nifty lost 36 points but retained the psychological 11,000 levels after closing at 11,017 levels.
Biocon net zooms 86% in first quarter
Fri, Jul 26, 2019
"Robust performance by biologics and small molecules business segments fuelled the growth in the first quarter. Investments in biosimilars are delivering expected results," said Biocon Chairperson Kiran Mazumdar-Shaw in a statement later here.
Stocks in Focus on April 25: Biocon, Indiabulls Housing to M&M Finance; here are the 5 newsmakers of the day
Thu, Apr 25, 2019
Domestic stocks market reported sharp gains, snapping the losses of three sessions, to end in a green mark on Wednesday, April 24, 2019.
Stocks in Focus on April 23: Essel Propack, Biocon to McLeod Russel; here are the 5 newsmakers of the day
Tue, Apr 23, 2019
Domestic stocks market logged strong losses on Monday, April 22, 2019, as global crude prices spiked up and went up to its highest levels in almost six months as the US government reportedly said it won't renew waivers to allow buyers to buy Iranian crude.
Christiane Hamachar becomes new CEO of Biocon Biologicals
Sat, Mar 02, 2019
Being a woman leader, Shaw believes Hamachar brings a diversity perspective which is integral to the company`s leadership journey.
Top 5 stocks in focus on July 5: Biocon, Yes Bank to Bharat Road, here are the 5 newsmakers of the day
Thu, Jul 05, 2018
Religare Finvest Limited has filed an insolvency application against Bharat Road for initiation of Corporate Insolvency Resolution process against the Company, claiming a default of about Rs 51.30 crore.
FAST MONEY: Phoenix Mills, Biocon among 20 intraday money-making ideas
Mon, Jun 25, 2018
S&P500 mini futures fell as much as 0.5 per cent in early trade while MSCI's broadest index of Asia-Pacific shares outside Japan fell 0.2 per cent. Japan's Nikkeilost 0.4 percent.
Biocon share price hits lifetime high on USFDA approval to cancer drug; stock jumps 6%
Tue, Jun 05, 2018
Fulphila is the first FDA-approved biosimilar to Neulasta and the second biosimilar from Mylan and Biocon’s joint portfolio approved in the US Mylan anticipates launching Fulphila in the coming weeks.
Anil Singhvi's Market Strategy June 5: 10,600 and 26,300 to be a deciding level in Nifty and BankNifty
Tue, Jun 05, 2018
Anil Singhvi suggests that traders reduce their buying positions on Nifty and BankNifty if it closes below the mark of 10,600 and 26,000 respectively.
I-T busts refund fraud, claims nexus between employees of top companies, CA
Thu, Jan 25, 2018
The Income Tax Department today claimed to have busted a racket of extracting fraudulent tax refunds by employees of bellwether companies like IBM, Vodafone and Infosys in alleged connivance with a Chartered Accountant (CA) in Bengaluru, the IT capital of the country.
Biocon Q3 net profit tanks 46%
Wed, Jan 24, 2018
The company said the fall in profit was due to increase in interest and depreciation costs related to Malaysia operations and lower licensing income
Biocon arm widens partnership terms with Bristol-Myers Squibb
Tue, Nov 14, 2017
Biocon's contract research arm Syngene International has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb till 2026.
Forbes list of world’s billionaires: These four Indian women are on the list
Fri, Jul 28, 2017
Forbes list of world's billionaires named only four Indian women. Most of whom had inherited their wealth from family businesses.
Biocon Q3 net up 65% to Rs 171 crore
Wed, Jan 25, 2017
Biotechnology major Biocon today reported a 64.55 per cent rise in its consolidated net profit to Rs 171.3 crore for the third quarter ended December 31, led by robust growth of biologics business.
Fire accident at Biocons' one Syngene Lab, shares tumble
Tue, Dec 13, 2016
It said, "Syngene is in the process of assessing the extent of damage to the building and equipment and also implementating a business continuity plan to minimize impact on operations."